American Oncology Network, Inc.

American Oncology Network, Inc.

AONC
American Oncology Network, Inc.US flagOther OTC
10.00
USD
-2.00
- -
292.48MMarket Cap
American Oncology Network, Inc.
AONC
(Other OTC)

Recent

price

10.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2020
2021
2022
2023
2024
TTM
FRC
76.03
99
120.61
191.34
- -
164.08
Revenue per Share
2.3
-0.01
0.27
-1.36
- -
-0.89
Basic EPS, GAAP
2.63
-3.64
-1.47
-4.55
- -
-2.42
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
6.25
6.52
-24.2
- -
-9.53
Book Value per Share
- -
6.13
6.38
0.67
- -
2.76
Tangible Book Value per Share
10
10
10
7
- -
11
Basic Weighted Avg Shares
725
944
1,150
1,279
1,759
1,759
Sales/Revenue/Turnover
3.05
0.1
0.77
-1.4
-0.91
-0.91
Operating Margin (%)
4
6
17
17
19
19
Depreciation Expense
22
- -
3
-6
-4
-4
Net Income, GAAP
- -
129.58
- -
- -
- -
- -
Effective Tax Rate (%)
3.03
-0.01
0.23
-0.43
-0.23
-0.23
Profit Margin (%)
- -
89
101
109
115
115
Working Capital
- -
64
118
120
135
135
LT Debt
- -
60
62
71
108
108
Total Equity
- -
-0.44
5.65
- -
- -
- -
Return on Invested Capital (%)
- -
-0.85
3.84
- -
- -
- -
Return on Capital (%)
- -
-0.35
4.26
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Jun'24
Sep'24
Dec'24
ST Debt
13
12
12
LT Borrowings
88
88
87
LT Finance Leases
46
44
48
Preferred Equity and Hybrid Capital
65
65
65
Shares Outstanding
13
13
27
Market Capitalization
9
42
54

Working Capital

FRC

in mil. unless spec.
Jun'24
Sep'24
Dec'24
Total Current Assets
306
271
331
Cash, Cash Equivalents & STI
55
19
73
Accounts Receivable, Net
125
128
129
Inventories
54
49
61
Total Current Liabilities
232
200
217
Payables & Accruals
196
162
176
ST Debt
13
12
12
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
52.74%
Free Cash Flow
- -
- -
-14.82%
Net Income, GAAP
- -
- -
-28.31%
Sales/Revenue/Turnover
- -
- -
37.55%
Total Cash Common Dividend
- -
- -
54.94%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
297
300
- -
- -
1,150
2023
304
315
336
324
1,279
2024
364
434
470
491
1,759

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
0.27
2023
- -
- -
-0.61
- -
-1.36
2024
-1.22
0.2
-0.19
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Business
American Oncology Network, Inc. operates as a physician-led network delivering integrated oncology care and practice management services primarily to community oncology practices across the United States. Founded in 2017 and headquartered in Fort Myers, Florida, the company provides a comprehensive suite of products and services including value-based cancer care, clinical laboratory and pathology services, specialty pharmacy, revenue cycle management, electronic medical records integration, care management, and ancillary support services tailored for oncology practices. American Oncology Network supports its network physicians with practice management expertise, administrative infrastructure, and technology platforms designed to enhance patient outcomes while enabling physicians to operate independently. The company’s network encompasses over 240 providers across 21 states, emphasizing community-centered, high-quality cancer care. Recent major changes include its 2023 completion of a reverse merger with Digital Transformation Opportunities Corp., which resulted in its listing on the Nasdaq under the ticker AONC and positioned the company with a pro forma enterprise valuation of approximately $500 million. The merger brought leadership continuity and expanded operational capacity. Additionally, American Oncology Network has extended and deepened its strategic partnerships, notably with AmerisourceBergen to scale its value-based oncology care delivery model nationally, leveraging AmerisourceBergen’s pharmaceutical distribution, supply chain management, technology, analytics solutions, and specialty pharmacy program support. The company continues to expand its network and service offerings through strategic collaborations and investments aimed at delivering comprehensive, cost-effective oncology care within community settings. The company targets community oncology providers seeking to improve clinical outcomes and financial sustainability within the evolving healthcare landscape.

Company News

APIChatGPT
  • Bay Hematology Oncology and American Oncology Network Welcome Dr. Bill Gai

  • American Oncology Network and CanCare, Inc. Announce Partnership to Provide Whole-Person Cancer Care, Combining Physical and Emotional Support for Patients Nationwide

  • American Oncology Network and Colla Health Partner to Expand Whole-Person Cancer Care and Behavioral Health Support in Community Oncology

  • Zangmeister Cancer Center Becomes Affiliate of Ohio State University's James Cancer Network, Expanding Access to Exceptional Community-Based Cancer Care Across Central Ohio

  • Elkhart Clinic Joins American Oncology Network, Becomes Elkhart Hematology and Oncology

  • The Center for Cancer and Blood Disorders receives authorization to administer FDA-approved CAR T-cell therapy; begins treating first community oncology patient in Maryland-area clinic

  • American Oncology Network to Participate in 11 Sessions at 2026 Community Oncology Alliance Annual Conference

  • RKV Medical Center Joins American Oncology Network as First Partner Practice in Oklahoma

  • American Oncology Network Welcomes Robert J. McDonald, MD, FACNM, as Radiology Medical Director and In-House Reading Radiologist

  • American Oncology Network Presents 15 Research Abstracts at ASCO Quality 2025

  • American Oncology Network Reports Strong Growth and Record Milestones in 2025

  • American Oncology Network Expands Arkansas Presence, Adds Conway Hematology Oncology to National Network

  • American Oncology Network Central Lab Receives Reaccreditation from College of American Pathologists

  • Heartland Oncology and Hematology Oncologist Named 2025 Advocacy Champion by the Association for Clinical Oncology (ASCO)

  • American Oncology Network Appoints Terri Casey as Chief Human Resources Officer

  • MidAmerica Cancer Care Opens New Medical Oncology Clinic in Kansas City, Kansas

  • American Oncology: A Buy Rating For Bold Growth Investors

  • Woodlands Cancer Institute Relocates Its Medical Oncology Clinic in The Woodlands, Texas

  • Florida Oncology and Hematology Relocates Fort Myers Clinic

  • American Oncology Network Appoints Charlie Goddard as General Counsel